Abstract
Abstract
Background
Symptomatic breast hypertrophy affects the quality of life of a large number of women globally. Many reduction mammoplasty techniques have been described for patients with breast hypertrophy. The aim of this study was to provide our clinic’s experience in utilizing the modified superomedial pedicle breast reduction technique in specific patients suffering from breast hypertrophy, with sternal notch-to-nipple distance of more than 33 cm.
Method
Our study included twenty patients who underwent, from January 2022 to December 2023, the modified superomedial pedicle breast reduction technique due to symptomatic breast hypertrophy with sternal notch-to-nipple distance of more than 33 cm in the Plastic and Reconstructive Surgery Department at Nicosia General Hospital in Cyprus. Patient demographics, comorbidities, pre- and postoperative breast anthropometric measurements and surgical complications were recorded and analyzed.
Results
The average age at the time of the reduction was 48 years. The mean preoperative body mass index was 28.52 kg/m2. Patients’ comorbidities included one (5%) patient with diabetes, seven (35%) with obesity and three (15%) with hypertension. The mean preoperative sternal notch-to-nipple distance was 35.25 cm for the right breast and 34.90 cm for the left breast, while the mean postoperative was 20.65 cm for both breasts. The total mean resection weight of both breasts was 1643.45 g. Surgical complications were minor including two (10%) cases of local hematoma and one (5%) case of T-Junction wound breakdown. All patients were relieved from their preoperative symptoms and were satisfied with the final result.
Conclusion
Our modified superomedial pedicle technique is a safe, effective and versatile pedicle to be used with many advantages, in specific patients suffering from breast hypertrophy with sternal notch-to-nipple distance of more than 33 cm, including its shape and rotational abilities, viability of the nipple and excellent outcome of glandular plication and breast reshaping.
Level of Evidence IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Funder
European University Cyprus
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. ISAPS (2023) Global survey 2022: Full report and press releases. Available from: https://www.isaps.org/discover/about-isaps/global-statistics/reports-and-press-releases/global-survey-2022-full-report-and-press-releases/. Cited 2024 Feb 18
2. Kalliainen LK, ASPS Health Policy Committee (2012) ASPS clinical practice guideline summary on reduction mammaplasty. Plast Reconstr Surg 130(4):785–789. https://doi.org/10.1097/PRS.0b013e318262f0c0
3. Agbenorku P, Agamah G, Agbenorku M, Obeng M (2012) Reduction mammaplasty in a developing country: a guideline for plastic surgeons for patient selection. Aesthetic Plast Surg 36(1):91–96. https://doi.org/10.1007/s00266-011-9750-8
4. Stahl S, Dannehl D, Daigeler A, Jorge C, Brendlin A, Hagen F, Santos Stahl A, Feng YS, Nikolaou K, Estler A (2023) Definitions of abnormal breast size and asymmetry: a cohort study of 400 women. Aesthetic Plast Surg 47(6):2242–2252. https://doi.org/10.1007/s00266-023-03400-4
5. Dafydd H, Roehl KR, Phillips LG, Dancey A, Peart F, Shokrollahi K (2011) Redefining gigantomastia. J Plast Reconstr & Aesthet Surg: JPRAS 64(2):160–163. https://doi.org/10.1016/j.bjps.2010.04.043